A group of scientists working out of Washington State University and the University of Pennsylvania have developed a high-tech diagnostic device that isn't merely capable of studying a sample in order to make a disease diagnosis, but is actually capable of checking up to 96 samples simultaneously.
Dubbed the mReader, this particular diagnostic device comes equipped with 96 distinct sample compartments designed to hold the fluid of choice obtained from the patient. A special substance can then be added to the samples, prompting them to change color if the biological component of interest is present. The device then takes a photo of the sample, before analyzing it with the help of an algorithm-driven computer.
This diagnostic device costs only $50 to make in prototype form, and with that number set to fall further once the device is mass-produced, it's clear that the mReader is poised to be a revolutionary gadget in the medical field.
Multitasking Diagnostic Devices
The 'mReader' Can Diagnose 96 Patient Samples Simultaneously
Trend Themes
1. High-throughput Diagnostics - The mReader's ability to analyze up to 96 samples simultaneously opens up opportunities for faster and more efficient diagnostic processes.
2. Color-based Detection - The mReader's use of color changes in samples to indicate the presence of biological components could disrupt traditional diagnostic methods.
3. Low-cost Diagnostic Devices - The mReader's affordable price of $50 and potential for further cost reduction through mass production could make advanced diagnostics more accessible.
Industry Implications
1. Medical Technology - The mReader device presents disruptive innovation opportunities in the field of medical technology, offering an advanced yet affordable diagnostic solution.
2. Laboratory Equipment - The mReader's high-throughput capabilities and color-based detection could disrupt the laboratory equipment industry by offering improved efficiency and accuracy.
3. Biotechnology - The mReader's ability to analyze multiple samples simultaneously could revolutionize the biotechnology industry by enabling faster and more cost-effective research and development.